摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-benzoylphenyl)-2-methylpropanoic acid

中文名称
——
中文别名
——
英文名称
2-(3-benzoylphenyl)-2-methylpropanoic acid
英文别名
fenofibric acid;Methyl ketoprofen
2-(3-benzoylphenyl)-2-methylpropanoic acid化学式
CAS
——
化学式
C17H16O3
mdl
——
分子量
268.312
InChiKey
HGRGFZWEVKNHJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(3-benzoylphenyl)-2-methylpropanoic acid四丁基醋酸铵 作用下, 以 乙腈 为溶剂, 以63 %的产率得到phenyl(3-(prop-1-en-2-yl)phenyl)methanone
    参考文献:
    名称:
    电化学脱羧消除羧酸生成烯烃
    摘要:
    已经开发出一种在室温下将羧酸脱羧消除为烯烃的电化学策略。这种温和且无氧化剂的方法为传统热脱羧反应提供了一种绿色替代方案。结构多样的脂肪族羧酸,包括生物活性药物,以良好到优异的产率顺利转化为相应的烯烃。
    DOI:
    10.1021/acs.orglett.3c02997
  • 作为产物:
    参考文献:
    名称:
    电化学脱羧消除羧酸生成烯烃
    摘要:
    已经开发出一种在室温下将羧酸脱羧消除为烯烃的电化学策略。这种温和且无氧化剂的方法为传统热脱羧反应提供了一种绿色替代方案。结构多样的脂肪族羧酸,包括生物活性药物,以良好到优异的产率顺利转化为相应的烯烃。
    DOI:
    10.1021/acs.orglett.3c02997
点击查看最新优质反应信息

文献信息

  • PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN
    申请人:FUJIFILM Wako Pure Chemical Corporation
    公开号:US20190055210A1
    公开(公告)日:2019-02-21
    An object of the present invention is to provide a photocuring method, which makes it possible to rapidly and efficiently obtain a crosslinked product (resin), a compound used in the photocuring method, and a photocuring resin composition containing the compound. The present invention relates to a photocuring method, which comprises a step 1 and a step 2 performed after the step 1, a compound used in the photocuring method, and a photocuring resin composition containing the compound. Step 1: this is a step in which in the presence of (A) compound having a carbonyl group generating a radical by photoirradiation and a carboxyl group decarboxylated by photoirradiation, (B) silane coupling agent having a mercapto group or a (meth)acryl group is reacted with (C) water under acidic conditions to obtain (D) silane compound having a mercapto group or a (meth)acryl group and at least one silanol group. Step 2: this is a step in which in the presence of the compound (A) and (E) compound having a carbonyl group generating a radical by photoirradiation and a group generating a base by being decarboxylated by photoirradiation, the compound (A) and the compound (E) are irradiated with light to create alkaline conditions in a reaction system by decarboxylating the carboxyl group of the compound (A) and generating a base from the compound (E), and radicals are generated from the compound (A) and the compound (E) to generate a crosslinked product containing a constitutional unit derived from the silane compound (D) from the silane compound (D) and, if necessary, from (F) compound having two or more polymerizable unsaturated groups.
    本发明的一个目标是提供一种光固化方法,该方法使得能够快速高效地获得交联产物(树脂),以及用于光固化方法的化合物和含有该化合物的光固化树脂组合物。本发明涉及一种光固化方法,该方法包括在步骤1和步骤2之后执行的步骤1和步骤2,以及用于光固化方法的化合物和含有该化合物的光固化树脂组合物。步骤1:这是一个步骤,在该步骤中,在(A)具有通过光照生成自由基的羰基和通过光照脱羧生成羧基的化合物的存在下,(B)具有巯基或(甲基)丙烯基的硅烷偶联剂在酸性条件下与(C)反应,以获得具有巯基或(甲基)丙烯基和至少一个醇基团的(D)硅烷化合物。步骤2:这是一个步骤,在该步骤中,在化合物(A)和(E)具有通过光照生成自由基的羰基和通过光照脱羧生成碱基的化合物的存在下,通过照射光线使化合物(A)和化合物(E)在反应系统中产生碱性条件,通过脱羧化合物(A)的羧基并从化合物(E)中生成碱基,并从化合物(A)和化合物(E)中生成自由基,从而生成包含从硅烷化合物(D)派生的构造单元的交联产物,如果需要,还可以从具有两个或更多可聚合不饱和基团的化合物(F)中派生。
  • HETEROAROMATIC RING COMPOUNDS
    申请人:Sumitomo Pharmaceuticals Company, Limited
    公开号:EP1201661A1
    公开(公告)日:2002-05-02
    Heteroaromatic ring compounds or pharmaceutically acceptable salts thereof, which have excellent characteristics and have strong curative effects to immuno-imbalance and choronic inflammation. Representative is the compound of the formula:
    杂芳香环化合物或其药学上可接受的盐类,具有优良的特性,对免疫平衡和络脉炎症有很强的疗效。具有代表性的是式中的化合物:
  • Photocuring method, compound and composition used therein
    申请人:FUJIFILM Wako Pure Chemical Corporation
    公开号:US10774062B2
    公开(公告)日:2020-09-15
    An object of the present invention is to provide a photocuring method, which makes it possible to rapidly and efficiently obtain a crosslinked product (resin), a compound used in the photocuring method, and a photocuring resin composition containing the compound. The present invention relates to a photocuring method, which comprises a step 1 and a step 2 performed after the step 1, a compound used in the photocuring method, and a photocuring resin composition containing the compound. Step 1: this is a step in which in the presence of (A) compound having a carbonyl group generating a radical by photoirradiation and a carboxyl group decarboxylated by photoirradiation, (B) silane coupling agent having a mercapto group or a (meth)acryl group is reacted with (C) water under acidic conditions to obtain (D) silane compound having a mercapto group or a (meth)acryl group and at least one silanol group. Step 2: this is a step in which in the presence of the compound (A) and (E) compound having a carbonyl group generating a radical by photoirradiation and a group generating a base by being decarboxylated by photoirradiation, the compound (A) and the compound (E) are irradiated with light to create alkaline conditions in a reaction system by decarboxylating the carboxyl group of the compound (A) and generating a base from the compound (E), and radicals are generated from the compound (A) and the compound (E) to generate a crosslinked product containing a constitutional unit derived from the silane compound (D) from the silane compound (D) and, if necessary, from (F) compound having two or more polymerizable unsaturated groups.
    本发明的目的是提供一种光固化方法,该方法可以快速有效地获得交联产品(树脂)、光固化方法中使用的化合物以及含有该化合物的光固化树脂组合物。 本发明涉及一种光固化方法,它包括步骤 1 和在步骤 1 之后进行的步骤 2、光固化方法中使用的化合物以及含有该化合物的光固化树脂组合物。 步骤 1:这是一个步骤,在(A)具有通过光照射产生自由基的羰基和通过光照射脱羧的羧基的化合物存在下,(B)具有巯基或(甲基)丙烯酰基的硅烷偶联剂与(C)在酸性条件下反应,得到(D)具有巯基或(甲基)丙烯酰基和至少一个硅烷醇基的硅烷化合物。 步骤 2:这一步是在化合物(A)和(E)存在的情况下,化合物(A)和化合物(E)具有通过光照射产生自由基的羰基和通过光照射脱羧产生碱的基团,用光照射化合物(A)和化合物(E),通过脱羧化合物(A)的羧基和从化合物(E)中产生碱,在反应体系中形成碱性条件、并从化合物(A)和化合物(E)中生成自由基,以生成含有由硅烷化合物(D)和(如有必要)由具有两个或两个以上可聚合的不饱和基团的化合物(F)衍生出的结构单元的交联产物。
  • Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes
    作者:Matthew A. Windsor、Daniel J. Hermanson、Philip J. Kingsley、Shu Xu、Brenda C. Crews、Winnie Ho、Catherine M. Keenan、Surajit Banerjee、Keith A. Sharkey、Lawrence J. Marnett
    DOI:10.1021/ml3001616
    日期:2012.9.13
    Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid and the endocannabinoids 2-arachidonoylglycerol (2-AG) and arachidonoylethanolamide (AEA). We recently reported that (R)-profens selectively inhibit endocannabinoid oxygenation but not arachidonic acid oxygenation. In this work, we synthesized achiral derivatives of five profen scaffolds and evaluated them for substrate-selective inhibition using in vitro and cellular assays. The size of the substituents dictated the inhibitory strength of the analogs, with smaller substituents enabling greater potency but less selectivity. Inhibitors based on the flurbiprofen scaffold possessed the greatest potency and selectivity, with desmethylflurbiprofen (3a) exhibiting an IC50 of 0.11 mu M for inhibition of 2-AG oxygenation. The crystal structure of desmethylflurbiprofen complexed to mCOX-2 demonstrated a similar binding mode to other profens. Desmethylflurbiprofen exhibited a half-life in mice comparable to that of ibuprofen. The data presented suggest that achiral profens can act as lead molecules toward in vivo probes of substrate-selective COX-2 inhibition.
  • EP1201661
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫